Core Insights - Oriental Harbor Investment Master Fund sold 59,274 shares of ProShares UltraPro QQQ for an estimated $5.4 million, reducing its position to approximately 1.2 million shares valued at $124.2 million [1][2][6] Fund Positioning - After the sale, TQQQ represents 9.6% of the fund's reportable assets under management [3][8] - The fund's top holdings include Nvidia, Alphabet, and FNGU, indicating a strong focus on technology-driven strategies [6][7] Performance Metrics - As of the latest market close, TQQQ shares were priced at $101.13, reflecting a 33% increase over the past year, outperforming the S&P 500 by 20 percentage points [3][4][7] - The one-year total return for TQQQ stands at 44%, with a dividend yield of 0.65% [4] Investment Strategy - ProShares UltraPro QQQ aims to deliver daily returns consistent with the Nasdaq-100 Index through the use of financial instruments [5][9] - The fund is non-diversified, concentrating a significant portion of its assets in a limited number of holdings [11][12] Market Context - The trimming of TQQQ position by Oriental Harbor may be a strategic rebalancing move after strong returns, maintaining a high-conviction tilt toward technology growth [10]

“You should never ever ever ever ever buy a leveraged ETF"“I launched leveraged ETFs for 5 years. When I saw the math I asked: why would you ever trade one of these?""But that's the US stock market casino and like they throw shit over here at crypto and the most dogshit product exists over there."- Arthur Hayes ( @CryptoHayes ) discussing leveraged ETFs on his podcast with Tom Lee ( @fundstrat ) ...

Core Insights - ProShares Ultra S&P500 ETF (SSO) is identified as a potentially profitable swing trading instrument, but its 2X leverage factor introduces a risk of drift [1] Group 1: Drift and Leverage - The article explains the concept of "drift" in the context of leveraged ETFs, particularly focusing on SSO [1] - A total of 22 leveraged ETFs are reported on regarding their drift characteristics, with SSO being a primary focus [1] Group 2: Author Background - The author, Fred Piard, PhD, has over 30 years of experience in technology and is a quantitative analyst [1] - Fred runs the investing group Quantitative Risk & Value, which includes a portfolio of quality dividend stocks and tech innovation companies [1]

Core Viewpoint - The Direxion Daily Aerospace & Defense Bull 3X Shares (NYSEARCA: DFEN) is identified as a leveraged ETF that aims to track the US Aerospace and Defense sector, currently viewed as a good investment opportunity [1]. Group 1: Investment Analysis - The ETF is designed to provide three times the daily performance of the Aerospace and Defense sector, indicating a high-risk, high-reward investment strategy [1]. - The analysis is supported by a quantitative finance approach, incorporating machine learning and deep learning applications to assess financial markets [1]. Group 2: Research Background - The author has a background in quantitative finance with published research on commodity price forecasting and derivatives hedging, which adds credibility to the investment analysis [1]. - The insights shared are shaped by a combination of quantitative research and considerations of geopolitical factors and fundamentals [1].

Group 1: Fund Overview - Defiance ETFs launched the Defiance Daily Target 2X Long OSCR ETF (Ticker: OSCX), providing 2X daily exposure to Oscar Health, Inc. (NYSE: OSCR) [1][2] - The fund aims to deliver daily investment results of 200% of the daily performance of Oscar Health, utilizing derivatives like swaps and options [2][3] Group 2: Company Profile - Oscar Health, Inc. is a technology-driven health insurance company focused on making healthcare more accessible and affordable through innovative plan designs and digital platforms [3] - The company is recognized for being one of the first insurers built around a full-stack technology platform, transforming the insurance experience for individuals, families, and small businesses [3] Group 3: Investment Considerations - An investment in OSCX is not a direct investment in Oscar Health, Inc., and the fund is designed for knowledgeable investors who understand the risks associated with leveraged investments [4][6] - The fund is intended for short-term trading and may not be suitable for buy-and-hold investors due to the potential for significant losses over periods longer than one day [4][10]

Group 1 - The article discusses the analysis of oil and gas companies, focusing on identifying undervalued names in the sector, including balance sheet evaluations, competitive positioning, and development prospects [1] - It highlights the characteristics of a specific "short" crude oil ETF (SCO), which aims for a daily leveraged result through futures investments [2] - The cyclical nature of the oil and gas industry is emphasized, indicating that it experiences boom-bust cycles, requiring patience and experience for successful investment [2] Group 2 - The article does not provide any specific investment recommendations or advice, and it encourages investors to review company documents and press releases for their own investment qualifications [4][5] - There is a disclosure stating that the author has no current positions in the mentioned companies and does not plan to initiate any within the next 72 hours [3]

Group 1 - The article discusses the analysis of oil and gas companies, focusing on identifying undervalued names within the industry [1] - It highlights the cyclical nature of the oil and gas industry, characterized by boom and bust cycles, requiring patience and experience for successful investment [2] - The article mentions a specific ETF, ProShares UltraShort Bloomberg Crude Oil, which is leveraged and aims for a daily result through futures investments [2] Group 2 - The author emphasizes the importance of understanding a company's balance sheet, competitive position, and development prospects for investment decisions [1] - The article is part of a service that provides in-depth analysis to members, which includes insights not available on the free site [1]

Company Overview - Defiance ETFs has launched the Defiance Daily Target 2X Long PM ETF (Ticker: ZYN), which offers investors 2X daily exposure to the performance of Philip Morris International Inc. (NYSE: PM) [1][2] - Philip Morris International is a leading international tobacco company that manufactures and sells cigarettes, smoke-free products, and associated devices, focusing on transitioning adult smokers to less harmful alternatives through its IQOS platform [3] Fund Objectives and Structure - The ZYN fund aims to deliver daily investment results of 200% of the daily performance of Philip Morris International Inc., utilizing derivatives such as swaps and options to achieve its leveraged objectives [2] - The fund is designed for knowledgeable investors who understand the risks associated with seeking daily leveraged investment results and are willing to actively monitor their portfolios [4][10] Industry Context - The tobacco and reduced-risk product industry faces various challenges, including regulatory pressures, litigation risks, and changing consumer preferences, which could impact the performance of companies like Philip Morris International [9]

Core Viewpoint - Defiance ETFs has launched the Defiance Daily Target 2X Long ANET ETF (Ticker: ANEL), which offers investors 2X daily exposure to the performance of Arista Networks, Inc. (NYSE: ANET) [1][2]. Company Overview - Arista Networks is a global leader in cloud networking solutions, providing scalable and high-performance platforms for large data centers, enterprise networks, and cloud providers [3]. - The company focuses on software-driven architecture, network automation, and advanced AI-driven security, positioning itself as a key enabler of cloud computing and next-generation enterprise connectivity [3]. Fund Structure and Strategy - The ANEL fund aims to deliver daily investment results of 200% of the daily performance of Arista Networks, utilizing derivatives such as swaps and options to achieve its leveraged objectives [2]. - The fund is designed for knowledgeable investors who understand the risks associated with seeking daily leveraged investment results and are willing to actively monitor their portfolios [4]. Company Background - Defiance ETFs, founded in 2018, specializes in thematic, income, and leveraged ETFs, and is recognized for its innovative approach in the ETF market [5].

Core Viewpoint - Defiance ETFs has launched the Defiance Daily Target 2X Short LLY ETF (Ticker: LLYZ), which provides investors with 2X inverse daily exposure to the performance of Eli Lilly and Company, allowing retail investors to seek enhanced downside exposure without needing a margin account [1][3]. Group 1: Fund Overview - LLYZ aims to deliver daily investment results of -200% of the daily performance of Eli Lilly and Company, utilizing derivatives such as swaps and options to achieve its leveraged objectives [2]. - The fund is designed for knowledgeable investors who understand the risks associated with seeking daily leveraged inverse investment results and are willing to actively monitor their portfolios [4]. Group 2: Company Profile - Eli Lilly and Company is recognized as a global leader in the pharmaceutical industry, known for its innovative therapies in areas such as diabetes, oncology, immunology, and neuroscience [3]. - The fund offers targeted inverse exposure for traders looking for amplified downside exposure without the need for a margin account, distinguishing it from direct investments in Eli Lilly [3]. Group 3: Company Background - Defiance, founded in 2018, specializes in thematic, income, and leveraged ETFs, positioning itself as a leader in ETF innovation [5]. - The company focuses on empowering investors to take amplified positions in high-growth companies through its first-mover leveraged single-stock ETFs [5].